Notice ID: f60fbab0f3a14a218fcae38ea057806cAward NoticeAwardedArchived
6505--Bupropion HCL 12HR SA Tablets Effective 05/16/2026 - 05/15/2027
Awarded on December 10, 2025. Full description on SAM.gov.
Awarded tounder 36E79726D0012 (source: SAM.gov award notice)• $8.3M
Overview
- Posted
- December 10, 2025
- Notice type
- Award Notice
- NAICS
- 325412: Pharmaceutical Preparation Manufacturing
- Agency
- Department of Veterans Affairs
Notice details
- Office
- NAC PHARMACEUTICALS (36E797)
- Last updated
- Nov 6, 2026
- First published
- Last updated on SAM.gov
- Award date
- Dec 10, 2025
- Award amount (SAM.gov award notice)
- $8.3M
Identifiers
- Solicitation number
- 36E79725R0065
- Notice ID
- f60fbab0f3a14a218fcae38ea057806c
- Award number (PIID)
- 36E79726D0012
Description
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) #36E79725R0065 for an unrestricted procurement for Bupropion Hydrochloride (HCL) 12 hour (HR) Sustained Action (SA) Tablets, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC).
VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DoD s respective
Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. All unit of use packaging identified in the Schedule of Supplies, (Line items 1, 3, and 5, 60 count bottles) shall contain a safety-cap capable of having the outer part of the cap deshelled and / or a convertible cap to produce a non-safety cap and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number.
Solicitation #36E79725R0065 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about November 4, 2025, with a tentative closing date of November 18, 2025. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at SAM.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Deb Fassl. Questions can be e-mailed to Deborah.Fassl@va.gov.
The estimated annual requirements are as follows:
REQUIREMENT DESCRIPTION
ITEM
DESCRIPTION
SAFETY CAP
PKG SIZE
(Tablets per Bottle)
TOTAL ESTIMATED ANNUAL USAGE
(Bottles)
1
Bupropion HCL 12HR SA Tablets, 100mg
Yes
60
77,795
2
Bupropion HCL 12HR SA Tablets, 100mg
No
500
20,289
3
Bupropion HCL 12HR SA Tablets, 150mg
Yes
60
158,669
4
Bupropion HCL 12HR SA Tablets, 150mg
No
500
36,203
5
Bupropion HCL 12HR SA Tablets, 200mg
Yes
60
73,742
Award Overview
Award Number
36E79726D0012
Award Amount (SAM.gov award notice)
$8.3M
Award Date
Dec 10, 2025
Awardee
Awardee UEI
C1S5SQ88KY67
Awardee CAGE Code
8PNH3
Awardee Address
HAUPPAUGE, NY 11788, NY
Line Item Number
5
Original Solicitation
Notice ID: f60fbab0f3a14a218fcae38ea057806c
Posted Date: Dec 10, 2025
Original Response Deadline: Not specified
More From This Vendor
Top 5 most recent
- —Signed Nov 6, 2026
- —Signed Oct 28, 2026
- —Signed Sep 14, 2026
- —Signed Sep 11, 2026
- —Signed Sep 11, 2026
Contacts
Contracting Officer
Primary Contact
Documents
Lifecycle
- 6Version 6SolicitationArchived
6505--Bupropion Tablets 12hr SA Tablets
- 4Version 4Award NoticeArchivedCurrent
Type changed from Solicitation to Award Notice
6505--Bupropion HCL 12HR SA Tablets Effective 05/16/2026 - 05/15/2027
Other notices for this solicitation
- Pre-SolicitationRelated noticeOct 20, 2025
6505--Bupropion Tablets 12hr SA Tablets
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue a Request for Proposal (RFP) 36E79727R0010 for an unrestricted procurement for Nitroglycerin Patches, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DoD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. VA labels must be able to securely adhere over the successful offeror/contractor's label. This product does not require unit of use packaging, as identified in the Schedule of Supplies. Patches must be boxed and must contain the bar code. The outside box as well as the patch must be barcoded. Solicitation #36E79727R0010 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about December 1, 2026, with a tentative closing date of December 15, 2026. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at SAM.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Jacob Werling. Questions can be e-mailed to Jacob.Werling@va.gov. The estimated annual requirements are as follows: REQUIREMENT DESCRIPTION ITEM DESCRIPTION UNIT of USE PKG. SIZE (Patches per Box) TOTAL EST. ANNUAL USAGE (Boxes) 1 Nitroglycerin 0.1 mg Patch N 30 4,982 2 Nitroglycerin 0.2 mg Patch N 30 10,044 3 Nitroglycerin 0.4 mg Patch N 30 8,720 4 Nitroglycerin 0.6 mg Patch N 30 2,213 | - | Pre-Solicitation | 11/18/2026 |
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79727R0009 for an unrestricted procurement for MULTIVIT/OPHTH AREDS2/LUTEIN/ZEAXANTHIN CAP/TAB, for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. Solicitation #36E79727R0009 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about December 23, 2026, with a tentative closing date of January 13, 2027. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Chris Carthron. Questions can be e-mailed to Christopher.Carthron@va.gov. The estimated annual requirements are as follows: REQUIREMENT DESCRIPTION ITEM DESCRIPTION PACKAGE SIZE (Bottles) TOTAL ESTIMATED ANNUAL USAGE (Bottles) 1 MULTIVIT/OPHTH AREDS2/LUTEIN/ZEAXANTHIN CAP/TAB 120 829,230 | - | Pre-Solicitation | Open |
Please see attached documents. | - | Pre-Solicitation | 12/15/2026 |
Department of Veterans Affairs Pharmaceutical Prime Vendor 2028 Specialty Pharmacy RFI AMENDMENT 0002 The purpose of this amendment is to extend the response date for this Request for Information (RFI) from November 16, 2026, 11:00 AM Central Time to November 30, 2026, 11:00 AM Central Time. All other information in this notice, including Amendment 0001, remains unchanged. | - | Market Research | 11/30/2026 |
| - | Awarded | Open |
Additional Details
Solicitation Number
36E79725R0065
Archive Date
Feb 8, 2026
Office Address
HINES, IL, 60141